102 On the other hand, numerous teams are advocating for that incorporation of novel markers, like a advanced karyotype55 or epigenetic subsets, 27,28 into clinical exercise. All these novel prognostic and/or predictive types will need to be validated in cohorts of sufferers treated with focused brokers.translocations or amplifications on top of th